Deep Genomics has appointed Thong Q. Le as the new chair of its Board of Directors, succeeding Chip Baird, who will remain as a non-executive director. Le, a veteran in life sciences investment and currently with the Gates Foundation, will guide Deep Genomics as it focuses on advancing its AI-driven drug discovery platform and expanding collaborations. The leadership change supports the company’s efforts in developing its proprietary genomic medicine pipeline and strengthening its position at the intersection of AI and genomics. Le expressed enthusiasm for the role, highlighting the company’s mission to transform medicine discovery and development.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.citybiz.co/article/878326/deep-genomics-appoints-thong-q-le-as-chair-of-board-of-directors/
